1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsPfizer Foundation Inc. Grantmaking is sponsored by Pfizer Foundation Inc.. Pfizer Foundation Inc. is a corporate foundation based in NEW YORK, NY with assets of approximately $255,288,291.
Get alerted about grants like this
Save a search for “Pfizer Foundation Inc.” or related topics and get emailed when new opportunities appear.
Search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Pfizer: One of the world's premier biopharmaceutical companies Clinical Trials in Children Integrity and Transparency Plain Language Study Results Expanded Access & Compassionate Use Inflammation & Immunology PfizerPro for Professionals Patient Assistance Programs Behind the Science Features Patient Advocacy & Engagement Diversity, Equity, and Inclusion Environmental Sustainability Stem Cell Research Policy Working with Healthcare Professionals Prescription Value & Pricing Corporate Governance Overview Board Committees & Charters The Pfizer Board Policies Corporate Governance FAQs Research and Business Development Partnerships Submit Your Opportunities Suggestions within Pfizer.
com Pfizer is fighting for 8 cancer breakthroughs by 2030. Every inch. Every day.
Every moment. Matters. Join the fight against cancer and get screened.
In the fight against cancer, every screening, every result, every early detection matters. Join the fight against cancer and get screened at PfizerForAll. com/Screenings.
Pfizer Announces New Discount Program Through TrumpRx Americans who chose to self-pay can now access significant savings on list prices for 30+ Pfizer brands across women’s health, migraine, arthritis, rare diseases, and more.
Season Six of Science Will Win Podcast Takes on Cancer Pfizer's flagship podcast returns to dive into the latest in oncology: the latest challenges, the latest research, the latest treatment approaches, and the latest sources of progress and optimism keeping researchers going.
Behind the Science: A New Path to Tackling Metastatic Breast Cancer In recent decades, advances in breast cancer treatment have helped to improve health outcomes for many patients, but scientists remain vigilant in their quest to further reduce both the incidence and impact of the disease. Hiding in Plain Sight: The Racial Toll of Lyme Disease Lyme disease is the most common vector-borne illness in the United States.
New research indicates that people of color are more likely to develop more severe Lyme disease. Behind the Science: Breaking the Cycle of C. difficile The human gut contains a variety of bacteria and other microorganisms comprising the microbiome, and that’s a good thing!
Clostridioides difficile, also known as C. difficile, is one such bacterium. Every product is the result of 1,500 scientists overseeing more than 500,000 lab tests and over 36 clinical trials before the first prescription.
Pfizer RxPathways connects eligible patients to a range of assistance programs that offer insurance support, co-pay help, and medicines for free or at a savings. Starting with Charles Pfizer inventing an almond-flavored antiparasite medicine in 1849, our people have always been innovators and trailblazers, committed to finding the next cure.
Pipeline Snapshot as of February 3, 2026 Explore the Product Pipeline Download Complete Pipeline PDF Revolutionary medicines enable us to enrich and extend life for people living with all types of diseases. View All Internal Medicine We’re developing therapies to treat, slow, or prevent disease progression and improve the quality of life for patients with obesity, type 2 diabetes, and cardiovascular and kidney diseases.
Inflammation & Immunology View All Inflammation & Immunology We look for treatments that provide more than just symptom relief, in order to address the root cause of chronic inflammatory diseases at a molecular level Vaccines are the single most important innovation in the science of health to significantly reduce the threat of diseases that were once widespread and oftentimes fatal.
Pipeline & Clinical Trials Cancer treatment needs to be transformed across the entire landscape to significantly improve the lives of cancer patients worldwide. An Accord for a Healthier World Where people live shouldn’t impact the quality of their healthcare and income shouldn’t determine health outcomes.
Learn More About The Accord communications from Pfizer Receive the latest news from Pfizer in our monthly The Breakthrough newsletter and email alerts on a variety of topics. This information—including product information—is intended only for residents of the United States. The products discussed herein may have different labeling in different countries.
Based on current listing details, eligibility includes: See the Pfizer Foundation Inc. website for complete eligibility requirements. Applicants should confirm final requirements in the official notice before submission.
Current published award information indicates Up to $12,764,415 Always verify allowable costs, matching requirements, and funding caps directly in the sponsor documentation.
The current target date is rolling deadlines or periodic funding windows. Build your timeline backwards from this date to cover registrations, approvals, attachments, and final submission checks.
Federal grant success rates typically range from 10-30%, varying by agency and program. Build a strong proposal with clear objectives, measurable outcomes, and a well-justified budget to improve your chances.
Requirements vary by sponsor, but typically include a project narrative, budget justification, organizational capability statement, and key personnel CVs. Check the official notice for the complete list of required attachments.
Yes — AI tools like Granted can help research funders, draft proposal sections, and check compliance. However, always review and customize AI-generated content to reflect your organization's unique strengths and the specific requirements of the solicitation.
Review timelines vary by funder. Federal agencies typically take 3-6 months from submission to award notification. Foundation grants may be faster, often 1-3 months. Check the program's timeline in the official solicitation for specific dates.
Many federal programs offer multi-year funding or allow competitive renewals. Check the official solicitation for continuation and renewal policies. Non-competing continuation applications are common for multi-year awards.
The J.M.K. Innovation Prize is a grant from The J.M. Kaplan Fund recognizing early-stage social entrepreneurs working on environmental, heritage, and social justice challenges. The prize rewards individuals and organizations demonstrating innovative, entrepreneurial approaches to enduring problems. Applications for the 2025 prize were accepted February 11 through April 25, 2025 via an online portal. Spanish-language applications are welcomed, and a Spanish application form is available for download. The prize is biennial and open to a broad range of applicants across the United States working on forward-thinking solutions at the intersection of environment, community, and cultural heritage.
Drinking Water State Revolving Fund (DWSRF) is a financial assistance program from NYS EFC and NYS Department of Health providing low-interest loans and grants to upgrade drinking water infrastructure in New York State. Eligible borrowers include community water systems and nonprofit non-community water systems. Projects must be listed on the Department of Health's Intended Use Plan (IUP) before applying. The program prioritizes projects addressing public health risks, aging infrastructure, and emerging contaminant compliance, with enhanced funding available through the Infrastructure Investment and Jobs Act.